NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Heart Disease Weekly


Research on Brucellosis discussed by N. Mohandas and co-researchers



*
Heart Disease Weekly Library
Library Home

This article was published in Heart Disease Weekly, which you can subscribe to online.

NewsRx
NewsRx
2009 JUL 12 - (NewsRx.com) -- "Human brucellosis is caused by one of the three species of Brucella: Brucella mellitensis, B. abortus, and B. suis.Worldwide, the incidence of human brucellosis ranges from <0.01 to >200 per 100,000 population. Cardiovascular complications occur in <2%, but accounts for most of the mortality," researchers in Manipal, India report.

"Brucella endocarditis usually involves normal native aortic valves in 75% of cases. A combination of antibiotics and valve replacement is the most acceptable treatment. So far only 15 adult cases have been reported as having been cured with medical therapy alone," wrote N. Mohandas and colleagues.

The researchers concluded: "We report another case treated successfully with antibiotics alone.."

Mohandas and colleagues published their study in Tropical Doctor (Can brucella endocarditis be treated successfully with medical therapy alone' Tropical Doctor, 2009;39(2):123-124).

For additional information, contact N. Mohandas, Kasturba Med College & Hospital, Dept. of Medical, Manipal, Karnataka, India.

Publisher contact information for the journal Tropical Doctor is: Royal Society Medicine Press Ltd., 1 Wimpole Street, London W1G 0AE, England.

Keywords: India, Manipal, Brucellosis, Cardiology, Cardiovascular, Coronary Artery Disease, Endocarditis, Heart Disease, Therapy, Treatment.

This article was prepared by Heart Disease Weekly editors from staff and other reports. Copyright 2009, Heart Disease Weekly via NewsRx.com.

NewsRx Passes
Advertisement
------------------------
Security by Verisign PR Login